Order Article Reprints

Rutz J, Maxeiner S, Grein T, Sonnenburg M, Khadir SE, Makhatelashvili N, Mann J, Xie H, Cinatl J, Thomas A, et al. Allyl-, Butyl- and Phenylethyl-Isothiocyanate Modulate Akt–mTOR and Cyclin–CDK Signaling in Gemcitabine- and Cisplatin-Resistant Bladder Cancer Cell Lines. International Journal of Molecular Sciences. 2022; 23(19):10996. https://doi.org/10.3390/ijms231910996

Rutz, Jochen, Sebastian Maxeiner, Timothy Grein, Marlon Sonnenburg, Salma El Khadir, Nino Makhatelashvili, Johanna Mann, Hui Xie, Jindrich Cinatl, Anita Thomas, and et al. 2022. "Allyl-, Butyl- and Phenylethyl-Isothiocyanate Modulate Akt–mTOR and Cyclin–CDK Signaling in Gemcitabine- and Cisplatin-Resistant Bladder Cancer Cell Lines" International Journal of Molecular Sciences 23, no. 19: 10996. https://doi.org/10.3390/ijms231910996

Rutz, J., Maxeiner, S., Grein, T., Sonnenburg, M., Khadir, S. E., Makhatelashvili, N., Mann, J., Xie, H., Cinatl, J., Thomas, A., Chun, F. K.-H., Haferkamp, A., Blaheta, R. A., & Tsaur, I. (2022). Allyl-, Butyl- and Phenylethyl-Isothiocyanate Modulate Akt–mTOR and Cyclin–CDK Signaling in Gemcitabine- and Cisplatin-Resistant Bladder Cancer Cell Lines. International Journal of Molecular Sciences, 23(19), 10996. https://doi.org/10.3390/ijms231910996